EZR and cancer: E2 has been reported to rapidly promote the phosphorylation of the ezrin protein through GPER or ERβ, causing ezrin-dependent rearrangement of the cytoskeleton and F-actin remodeling, which stimulates the migration and invasion of ERα-negative cancer cells.